AngioDynamics
ANGO
154 hedge funds and large institutions have $332M invested in AngioDynamics in 2025 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 45 increasing their positions, 60 reducing their positions, and 15 closing their positions.
127% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 15
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
14% more funds holding
Funds holding: 135 → 154 (+19)
9% more capital invested
Capital invested by funds: $305M → $332M (+$27M)
5.28% more ownership
Funds ownership: 81.86% → 87.14% (+5.3%)
25% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 60
31% less call options, than puts
Call options by funds: $351K | Put options by funds: $510K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$12.8M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.76M |
| 3 |
BAM
Bastion Asset Management
Montreal,
Canada
|
+$6.88M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
+$5.19M |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$4.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$9.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6.44M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$5.08M |
| 4 |
JP Morgan Chase
New York
|
-$5.06M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.87M |
ANGO Hedge Fund Activity: Q1 2025 in Review
154 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2025, worth a combined $332M — up 8.9% from $305M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new ANGO positions and 15 closed out — a net gain of 19 holders — while 45 added to existing stakes and 60 trimmed.
The largest buyer was Armistice Capital, adding an estimated $12.8M. The largest seller was Millennium Management, cutting an estimated $9.7M.
- 154 institutional investors held AngioDynamics (ANGO) as of Q1 2025, up from 135 in Q4 2024.
- Funds reported $332M of AngioDynamics stock for Q1 2025, up 8.9% quarter-over-quarter.
- 34 funds opened new AngioDynamics positions in Q1 2025 and 15 closed out, a net change of +19 holders.
- The largest AngioDynamics buyer in Q1 2025 was Armistice Capital, an estimated $12.8M added.
- The largest AngioDynamics seller in Q1 2025 was Millennium Management, an estimated $9.7M sold.
Based on aggregated 13F filings for Q1 2025.